Investment
Features
FeesSafety
Academy
More
Pluang+

Compare i-80 Gold Corp. Common Shares (IAUX) vs ResMed Inc. (RMD) Price & Performance

i-80 Gold Corp. Common SharesTrade
ResMed Inc.Trade

Price performance (Past 24H)

Key statistics

i-80 Gold Corp. Common Shares vs ResMed Inc. — how do they compare? i-80 Gold Corp. Common Shares trades at $1.49 (market cap $1.34B), while ResMed Inc. trades at $237 (market cap $32.99B). The key difference: ResMed Inc. is far larger — about 24.6× i-80 Gold Corp. Common Shares's market cap, and ResMed Inc. pays a 1.13% dividend while i-80 Gold Corp. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold i-80 Gold Corp. Common Shares for 0 Days and ResMed Inc. for 51 Days on average.

IAUXRMD
Market Cap
$1.34B$32.99B
Volume
3,239,7251,023,381
Sector
Basic MaterialsHealth
52-Week High
$2.08$275.96
52-Week Low
$0.89$182.82
Typical Hold Time
0 Days51 Days
Enterprise Value
$1.32B$32.35B
Dividend Yield
—1.13%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

i-80 Gold Corp. Common Shares

IAUX trades at $1.54, down 2.53% today, with a neutral technical signal. The company shows significant financial challenges with a -198.82% net income margin and negative ROE of -71.66%, though revenue grew from $95M in 2025 to $130M in 2026. Recent positive developments include CEO purchasing 1 million shares and feasibility studies showing strong potential for Nevada gold projects. Analyst consensus remains unanimously bullish with 3 buy ratings.

While facing substantial profitability challenges, IAUX's development pipeline and CEO confidence suggest long-term potential. Key risks include persistent negative cash flow from operations and high debt levels. The stock presents a high-risk, high-reward opportunity dependent on successful project execution and gold price stability.

ResMed Inc.

ResMed (RMD) trades at $235.29, up 0.29% with strong technical momentum and bullish moving averages. The company demonstrates robust fundamentals with 27.2% net margins and consistent earnings beats in recent quarters. Recent news highlights include upcoming Q1 2027 earnings and management presentations at healthcare conferences, while analyst consensus remains positive with a $243.56 price target.

RMD presents a favorable investment case with strong profitability metrics and positive earnings momentum, though elevated valuation ratios and ongoing legal investigations warrant caution. The stock's technical strength supports near-term upside potential toward resistance levels, while fundamental growth drivers in sleep therapy demand provide long-term support.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IAUX
100% Buy0% Sell
Avg holding period · 0 Days
RMD

No sentiment data available yet.

Top news

Latest headlines on both assets

About i-80 Gold Corp. Common Shares

i-80 Gold Corp. is a mining company focused on developing and operating gold and precious-metals projects in Nevada, using a hub-and-spoke model centered on a processing facility to support multiple mine sites in the state.

Read more on IAUX →

About ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Read more on RMD →